review · SSRN Electronic Journal

Prevalence of Drug Resistance Associated Substitutions in Hepatitis C-Infected Patients Whose WHO-Recommended Direct Acting Agents for Initial Treatment and Retreatment Fails: A Systematic Review and Meta-Analysis

Seth Inzaule
Marco Vitória
Nathan Ford
Ashley Latona
Suzanne M. McCluskey
Philippa C. Matthews
S. Tchamgoué
Philippa Easterbrook
Olufunmilayo Lesi
Rachel Halford
Amalia Girón‐Callejas
William L. Irving
Geoff Dusheiko
Emma C. Thomson
Chris Duncombe
Michael R. Jordan

2023Open accessUniversity of Douala

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Hepatitis C virus research
HIV/AIDS drug development and treatment
Drug-Induced Hepatotoxicity and Protection

Sustainable Development Goals

3Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.2139/ssrn.4613660

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.